Madrigal Pharmaceuticals (MDGL) PT Raised to $375 at Oppenheimer
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $541.08 -0.28%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $375.00 (from $320.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Hindustan Unilever Ltd (HUVR:IN) PT Lowered to INR2,440 at HSBC
- Snowflake Inc. (SNOW) PT Raised to $450 at Freedom Broker
- Samsara Inc (IOT) PT Raised to $55 at BNP Paribas Exane
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
